No ARV shortage – Department of Health
The Department of Health has slammed media reports of shortages of 300mg formulations of ARV lamivudine this week as “sensational” in a statement released yesterday (8 January).
Health-e News reported the alleged stock outs on Thursday after the Treatment Action Campaign reported shortages of ARV and East Rand patients reported being turned away from clinics empty handed. The Gauteng Department of Health confirmed shortages of the 300mg tablets but re-iterated that there was no cause for alarm as smaller, 150mg formulations of the drug were still available.
“We wish to confirm that, there is a shortage of lamivudine 300mg, however, we do have lamivudine 150mg tablets in stock,” Gauteng Department of Health Spokesperson Steve Mabona was quoted as saying in the article. He urged health workers to consider dispensing a double dose of the smaller, 150mg-formulation in lieu of the usual 300mg tablets.
Mabona told Health-e News the shortage of higher dose tablets is being addressed. He blamed the fact that some patients were being turned away empty handed from clinics on a miscommunication between district pharmacies and clinics.
Yesterday, the National Department of Health Spokesperson Popo Maja re-iterated Mabona’s assurance in a statement saying that there was there is no crisis of ARVs in Gauteng or elsewhere in the country in a statement.
According to a Department of Health circular issued Thursday, the 300mg formulation of lamivudine will no longer be available on tender as many patients who take the tablet can take one of three other combination ARVs.
The Department of Health has urged clinicians to make use of these combination ARVs and to reserve use of smaller 150mg lamivudine tablets of children and complicated cases.
According to Maja, this information had also been circulated to clinicians via an earlier statement. – Health-e News.
An edited version of this story also appeared in The Saturday Star.
- Read the National Department of Health’s full statement
- Read the department’s advice for doctors and nurses
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
No ARV shortage – Department of Health
by lauralopez, Health-e News
January 9, 2016